₹10.52
+₹0.00 (+0.00%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹26 Cr
P/E
-1.25
ROE
-37.82%
ROCE
-21.59%
About Cian Healthcare Ltd
Cian Healthcare is engaged in manufacturing of multiple lines- tablets, capsules, soft gels, liquid orals, ointments/ creams & sachets, cosmetics. Our portfolio comprises of gynecology, haematinic, cardio- diabetic, orthopedic, pediatric, derma- cosmetic, and antibiotic, CNS, vitamins & nutrient products.
Founded
2003
CEO
N/A
Employees
185
HQ
Pune, India
About Cian Healthcare Ltd
Cian Healthcare is engaged in manufacturing of multiple lines- tablets, capsules, soft gels, liquid orals, ointments/ creams & sachets, cosmetics. Our portfolio comprises of gynecology, haematinic, cardio- diabetic, orthopedic, pediatric, derma- cosmetic, and antibiotic, CNS, vitamins & nutrient products.
Founded:2003
CEO:N/A
Employees:185
HQ:Pune, India
Finished Products
1Sales
₹157.19CrRaw Materials
1Raw Material Consumed
₹78.77Cr2Purchase of Traded Goods
₹1.48CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹11
52W Low
₹3
Volume1.37K
Avg VolumeN/A
Beta-1.24
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
-1.25x
Valuation
P/B Ratio
1.28x
Valuation
EPS
₹-8.41
Valuation
Dividend Yield
0.00%
Valuation
ROE
-37.82%
Profitability
ROCE
-21.59%
Profitability
Revenue by Segment
Contribution & growth by business line
PharmaceuticalsRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
87.1%
International
12.9%
Domestic87.1%
Export12.9%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.66x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
-23.4%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.